Real-World Outcome and Prognostic Factors Among HER2-Positive Metastatic Breast Cancer Patients Receiving Pyrotinib-Based Therapy: A Multicenter Retrospective Analysis

PURPOSE: To explore the efficacy, safety, and potential factors influencing efficacy and outcome of pyrotinib-based therapy in human epidermal growth factor receptor 2 (HER2)-positive metastatic breast cancer (MBC) in complex clinical practice. METHODS: Real-world data for HER2-positive MBC patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Jing, Sun, Xianglu, Du, Qianyu, Yao, Jinghao, Dai, Mengfen, Cheng, Qianqian, Xu, Han, Li, Yawei, Liu, Xiuli, Zhang, Mingliang, Zhou, Yongchun, Yang, Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9790158/
https://www.ncbi.nlm.nih.gov/pubmed/36575687
http://dx.doi.org/10.2147/BCTT.S385341

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9790158/
https://www.ncbi.nlm.nih.gov/pubmed/36575687
http://dx.doi.org/10.2147/BCTT.S385341

Ejemplares similares